Late Toxicity in High-risk Prostate Cancer Treated with Androgen Suppression and Hypofractionated Intensity Modulated Radiotherapy

被引：1
|
作者：
Drodge, S. [1 ]
Pervez, N. [1 ]
Ghosh, S. [1 ]
Mackenzie, M. [1 ]
Yee, D. [1 ]
Mihai, A. [1 ]
Murtha, A. [1 ]
Amanie, J. [1 ]
Fallone, G. [1 ]
Pearcey, R. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [31] Acute toxicity in patients with localized prostate cancer treated with high dose of Intensity Modulated Radiotherapy
    Gabriel, Nunez-Guardado
    Pomponio Jose, Lujan-Castilla
    Luia Felipe, Villanueva-Navarro
    Maria Yicel, Bautista-Hernandez
    Oscar, Rubio-Nava
    Michelle Aline, Villavicencio-Queijeiro
    Claudia, Marquez-Diaz
    GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (01): : 19 - 24
  • [32] ACUTE AND LATE TOXICITY OF PELVIC RADIOTHERAPY AND CONCOMITANT HYPOFRACTIONATED IMRT BOOST COMBINED WITH HORMONAL THERAPY FOR HIGH-RISK PROSTATE CANCER
    Quon, H.
    Loblaw, A.
    Morton, G.
    Sixel, K.
    Pang, G.
    Basran, P.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Thomas, G.
    Kiss, A.
    Deabreu, A.
    Cheung, P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S47 - S47
  • [33] LATE TOXICITY AFTER INTENSITY-MODULATED RADIOTHERAPY (IMRT) FOR PROSTATE CANCER
    Vandaele, F.
    Van Gestel, D.
    Goossens, J.
    Coelmont, A.
    Goor, C.
    Meijnders, P.
    Van den Weyngaert, D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S408 - S409
  • [34] Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity
    Valeriani, Maurizio
    Carnevale, Alessia
    Osti, Mattia Falchetto
    Minniti, Giuseppe
    De Sanctis, Vitaliana
    Agolli, Linda
    Bracci, Stefano
    Enrici, Riccardo Maurizi
    TUMORI, 2013, 99 (04) : 474 - 479
  • [35] Hypofractionated radiotherapy in high-risk prostate cancer using helical tomotherapy
    Pervez, N.
    Pearcey, R.
    Parliament, M.
    Yee, D.
    Amanie, J.
    Murtha, A.
    Pederson, J.
    Mihai, A.
    Mackenzie, M.
    Wachowicz, K.
    Fallone, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S94 - S94
  • [36] Effectiveness and toxicity of the intensity modulated radiotherapy (IMRT) as hypofractionated boost with prostate carcinoma
    Kosakowski, J.
    Welzel, G.
    Abo-Madyan, Y.
    Mai, S.
    Wertz, H.
    Wenz, F.
    Lohr, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 21 - 21
  • [37] Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
    Kapoor, Rakesh
    Bansal, Anshuma
    Kumar, Narendra
    Oinam, Arun S.
    INDIAN JOURNAL OF UROLOGY, 2016, 32 (03) : 210 - 215
  • [38] Acute- and late toxicity of patients with prostate cancer, who were treated with intensity-modulated radiotherapy
    Boehmer, D.
    Herschel, R.
    Badakhshi, H.
    Eichwurzel, I
    Wernecke, K. D.
    Hinkelbein, M.
    Budach, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 76 - 76
  • [39] Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer
    Bracci, S.
    Osti, M. F.
    Agolli, L.
    Bertaccini, L.
    De Sanctis, V.
    Valeriani, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S641 - S641
  • [40] Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate
    Reddy, K.
    Nelson, B. C.
    McCammon, R.
    Rusthoven, K. E.
    Newman, F.
    Kavanagh, B.
    Raben, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S376 - S376
12345